Anika Therapeutics
ANIK
ANIK
172 hedge funds and large institutions have $670M invested in Anika Therapeutics in 2017 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 65 increasing their positions, 54 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
0.19% less ownership
Funds ownership: 84.91% → 84.72% (-0.19%)
8% less capital invested
Capital invested by funds: $726M → $670M (-$55.9M)
Holders
172
Holding in Top 10
2
Calls
$809K
Puts
–
Top Buyers
| 1 | +$3.28M | |
| 2 | +$3.13M | |
| 3 | +$1.38M | |
| 4 |
HSA
Hussman Strategic Advisors
Ellicott City,
Maryland
|
+$1.35M |
| 5 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$1.18M |
Top Sellers
| 1 | -$6.14M | |
| 2 | -$3.76M | |
| 3 | -$2.3M | |
| 4 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$1.77M |
| 5 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$1.38M |